RLAY- Relay Therapeutics, Inc.

Name: Relay Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Relay Therapeutics, Inc. (RLAY) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RLAY is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Patel Sanjiv	1.45M	$23.03M	-
Pres	Bergstrom Donald A	420.0K	$6.67M	-
Other	Adams Brian	371.5K	$5.90M	-
Other	Rahmer Peter	276.6K	$4.39M	-
CFO	Catinazzo Thomas	215.7K	$3.42M	-

Activity

Buys and sells only

Transactions

10 filings · page 16

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 27, 2021	Adams Brian72	General Counsel	Sell	295	$33.10	$9,764.50	-1.2%	-7.2%	-55.2%
Nov 15, 2021	Catinazzo Thomas71	Senior Vice President, Finance	Sale+OE	22,500	$35.40	$796,500.00	-59.5%	-42.6%	-43.9%
Nov 15, 2021	Adams Brian72	General Counsel	Sale+OE	6,500	$35.42	$230,230.00	-20.5%	-42.6%	-43.9%
Oct 15, 2021	Bergstrom Donald A75	See Remarks	Sell	30,000	$34.15	$1,024,500.00	-39.7%	-24.5%	-42.8%
Sep 27, 2021	Catinazzo Thomas71	Senior Vice President, Finance	Sell	293	$36.87	$10,802.91	-1.9%	-14.1%	-37.7%
Sep 27, 2021	Bergstrom Donald A75	See Remarks	Sell	646	$36.87	$23,818.02	-0.8%	-14.1%	-37.7%
Sep 27, 2021	Adams Brian72	General Counsel	Sell	293	$36.87	$10,802.91	-1.1%	-14.1%	-37.7%
Sep 13, 2021	Adams Brian72	General Counsel	Sale+OE	6,500	$35.02	$227,630.00	-20.3%	-21.8%	-32.7%
Sep 13, 2021	Catinazzo Thomas71	Senior Vice President, Finance	Sale+OE	22,500	$35.00	$787,500.00	-59.1%	-21.8%	-32.7%
Jun 28, 2021	Adams Brian72	General Counsel	Sell	293	$35.81	$10,492.33	-1.1%	+4.1%	-54.5%

← PrevPage 16Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC